Phapros Strengthens Rheumatic Fever Prophylaxis Education at North Sumatra IDAI Scientific Symposium

Medan, July 2026 – PT Phapros Tbk demonstrated its commitment to improving the quality of healthcare services by participating in Pediatric Cardiology Update XIV, held in conjunction with the 16th Continuing Medical Education (PKB) program of the North Sumatra chapter of the Indonesian Pediatric Society (IDAI), on July 22–25, 2026, at Hotel Santika Premiere Dyandra, Medan. Under the theme “From Bench to Bedside: Comprehensive Management for Cardiac Problems in Children,” the event provided an educational forum for medical professionals in pediatric cardiology.

Pediatric Cardiology Update XIV brought together physicians and healthcare professionals to exchange knowledge and experience regarding developments in the diagnosis and management of pediatric heart conditions.

Phapros participated through an exhibition booth and a scientific symposium to strengthen education for healthcare professionals. At the booth, participants could learn about the company's pharmaceutical portfolio, including products relevant to the management of infectious diseases in accordance with clinical indications.

One of the supported sessions, Symposium 10, took place on Friday, July 24, 2026, from 10:10 to 10:45 a.m. Western Indonesia Time. Moderated by dr. Yazid Dimyati, M.Ked(Ped), Sp.A, Subsp. Neuro(K), the symposium addressed two topics in pediatric cardiology.

The first presentation, “Early Detection and Management for Acute Viral Myocarditis,” was delivered by Dr. dr. Ni Putu Veny Kartika Yantie, Sp.A, Subsp. Kardio(K), M.Sc. It highlighted the importance of early identification, diagnostic approaches, and management strategies for acute viral myocarditis in children.

The second presentation, “Antibiotic Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease,” was delivered by Dr. dr. Renny Suwarniaty, Sp.A, Subsp. Kardio(K). It focused on preventing recurrence of rheumatic fever and rheumatic heart disease through appropriate antibiotic prophylaxis.

Phapros also introduced two penicillin-based products: benzathine benzylpenicillin and phenoxymethylpenicillin (penicillin V). The educational effort emphasized rational antibiotic use, adherence to treatment, and prophylaxis based on physicians' clinical judgment.

Through its support for the symposium, Phapros reaffirmed its commitment to medical knowledge development and better healthcare services in Indonesia. Cooperation between the pharmaceutical industry and healthcare practitioners through scientific forums is expected to improve understanding of disease prevention and treatment in clinical practice.